Skip to content Skip to sidebar Skip to footer
Menu
Menu
Newsletter
Menu
Newsletter
American Tungsten
Coal Stocks
Whitehaven Coal (ASX:WHC) Surges After Triple Credit Rating Win- Buy, Hold, or Wait for a Better Entry?
Whitehaven Coal gets a refinancing boost, but coal risks remain Whitehaven Coal (ASX: WHC) climbed 6.7% to A$9.29 on Thursday after announcing it had received public credit ratings from S&P Global, Fitch, and Moody's, all with stable outlooks. For most companies, a credit rating is routine admin. For Whitehaven right now, it is something more…
March 13, 20260Comments
QMines
Lithium Stocks
Liontown (ASX: LTR) Falls on H1 Loss Despite Production Breakthrough- Is Now the Time to Buy?
Liontown’s production is improving, but lithium risks remain Liontown Resources (ASX: LTR) delivered H1 FY2026 results on March 11, leaving the market conflicted. On one hand, total revenue and other income more than doubled to A$208 million compared to the same time last year, and the underground mine at Kathleen Valley is genuinely performing well.…
March 13, 20260Comments
NEXTDC
Tech Stocks
Macquarie Technology (ASX:MAQ) Secures A$200M Government Backing – Is This the Buy Signal?
Macquarie Technology Wins A$200M Government Deal Macquarie Technology (ASX: MAQ) jumped on Wednesday after the federal government committed A$200 million to the company through the National Reconstruction Fund Corporation (NRFC). What makes this deal stand out is not just the size. It is the fact that no new shares were issued, meaning existing shareholders are…
March 12, 20260Comments
Evolution Mining
Mining Stocks
OzAurum (ASX: OZM) Jumps 5% on Key Permit Approval. Is This Junior Gold Stock a Buy?
OzAurum Moves Closer to Production OzAurum Resources (ASX: OZM) climbed 5.26% to A$0.10 after receiving environmental approval from the Western Australian government for Stage 1 operations at its Mulgabbie North gold project. For most junior miners, getting through the environmental approval process is the hardest and most unpredictable part of the entire development journey. The…
March 11, 20260Comments
Telix Pharmaceuticals
Healthcare Stocks
Orthocell (ASX: OCC) Lines Up UK Distributor for Remplir Ahead of Approval- Is Now the Time to Buy?
Orthocell Moves Closer to UK Growth Orthocell (ASX: OCC) just made a move that not every small-cap medtech company would make. Rather than waiting for regulatory approval before signing a UK distributor agreement, the company secured one early. On December 15, 2025, Orthocell submitted its application to the British Standards Institution seeking approval to sell…
March 11, 20260Comments

the Kick-ass Multipurpose WordPress Theme

Investing in the Year of the Rat
2020, the Golden Year
Market trouble spots to avoid in 2020
© 2026 Kicker. All Rights Reserved.

Add Your Heading Text Here